Weight Loss
US$ 23.41
semaglutide and prostate cancer Potential preventive properties of GLP-1 receptor agonists against cancer: a nationwide cohort study | Diabetologia semaglutide prostate cancer Metabolic Response
Description
Is long-term GLP-1 therapy safe for weight management
Cardiovasc Diabetol 2023;22(1)
Ozempic may increase hypoglycaemia risk when taken with insulin or sulfonylureas, requiring dose adjustments of these medications
Vishon J SUBRAMANI, MD GET THE LATEST NEWS Explore our latest articles on fasting, metabolic health, and nutrition
